Table 2.
Prospective randomized trials
| Reference study | N | Mean stone burden | Postoperative drainage | Additional hemostasis used | Analgesia requirement | Average Hb drop (g/dl) | Stone-free rates (%) | Length of stay | Complications |
|---|---|---|---|---|---|---|---|---|---|
| Agrawal et al. [27] | 101 | 3.8 cm2 | JJs | Nil | 81.7 mg MP | 0.36 g% | 100 | 21.8 h | — |
| Desai et al. [19] | 10 | 250 mm2 | JJs | Nil | 8.5 mg D | 4.2 g% | — | 3.4 days | — |
| Feng et al. [28] | 8 | 4.4 cm3 | JJs | Nil | 5.25 mg M | — | 85.7 | 1.9 days | |
| Singh et al. [30] | 30 | 750 mm | JJs | Diathermy | 6 mg M, 415 mg D | 1.2 g% | 100 | 2.1 days | UTI (2), Stent dysuria (2) |
N-Number of tubeless patients/renal unit; JJs-Double-J stent; MP- Meperadine; M-Morphine sulphate; D-Diclofenac sodium